Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nutritional Evaluation and Optimisation in Neonates (amino acid regimen and intravenous lipid composition in preterm parenteral nutrition)
2009-016731-34Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Mar 2010
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Vaminolact, SMOFlipid and Intralipid 10% in preterm birth (4 arms), sponsored by Imperial College London. Primary endpoint: Non-adipose (lean) body mass. Started Mar 2010; status: completed.
02
Drugs
VaminolactSMOFlipidIntralipid 10%
03
Conditions
preterm birth
Beyond the preview
Go deeper on 2009-016731-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016731-34.